Correlation Between Pharmagreen Biotech and Cannabis Suisse

Can any of the company-specific risk be diversified away by investing in both Pharmagreen Biotech and Cannabis Suisse at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmagreen Biotech and Cannabis Suisse into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmagreen Biotech and Cannabis Suisse Corp, you can compare the effects of market volatilities on Pharmagreen Biotech and Cannabis Suisse and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmagreen Biotech with a short position of Cannabis Suisse. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmagreen Biotech and Cannabis Suisse.

Diversification Opportunities for Pharmagreen Biotech and Cannabis Suisse

0.0

Correlation Coefficient

Pharmagreen Biotech  Cannabis Suisse

Pay attention - limited upside

The 3 months correlation between Pharmagreen and Cannabis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pharmagreen Biotech and Cannabis Suisse Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannabis Suisse Corp and Pharmagreen Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmagreen Biotech are associated (or correlated) with Cannabis Suisse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannabis Suisse Corp has no effect on the direction of Pharmagreen Biotech i.e., Pharmagreen Biotech and Cannabis Suisse go up and down completely randomly.

Pair Corralation between Pharmagreen Biotech and Cannabis Suisse

Given the investment horizon of 90 days Pharmagreen Biotech is expected to generate 2.39 times less return on investment than Cannabis Suisse. But when comparing it to its historical volatility, Pharmagreen Biotech is 2.68 times less risky than Cannabis Suisse. It trades about 0.15 of its potential returns per unit of risk. Cannabis Suisse Corp is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  1.98  in Cannabis Suisse Corp on July 27, 2025 and sell it today you would lose (0.40) from holding Cannabis Suisse Corp or give up 20.2% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pharmagreen Biotech  vs.  Cannabis Suisse Corp

Pharmagreen Biotech

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Pharmagreen Biotech are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile fundamental drivers, Pharmagreen Biotech demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Cannabis Suisse Corp

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Cannabis Suisse Corp are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile basic indicators, Cannabis Suisse demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pharmagreen Biotech and Cannabis Suisse

The main advantage of trading using opposite Pharmagreen Biotech and Cannabis Suisse positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmagreen Biotech position performs unexpectedly, Cannabis Suisse can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannabis Suisse will offset losses from the drop in Cannabis Suisse's long position.

The idea behind Pharmagreen Biotech and Cannabis Suisse Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.